CN
760-84-9
应用筛选条件
关键词:'760-84-9'
显示 1-17 共 17 条结果 关于 "760-84-9" 范围 技术文档
Lab Notebook Guidelines
54
.9
38
55
.8
45
58
.9
33
54
.9
38
88
.9
06
91
.2
24
92
.9
06
95
.9
6
(9
8)
10
1.
07
10
2.
91
13
8.
91
17
8.
49
LABORATORY NOTEBOOK ISSUANCE PAGE
54
.9
38
55
.8
45
58
.9
33
54
.9
38
88
.9
06
91
.2
24
92
.9
06
95
.9
6
(9
8)
10
1.
07
10
2.
91
13
8.
91
17
8.
49
LABORATORY NOTEBOOK ISSUANCE PAGE
54
.9
38
55
.8
45
58
.9
33
54
.9
38
88
.9
06
91
.2
24
92
.9
06
95
.9
6
(9
8)
10
1.
07
10
2.
91
13
8.
91
17
8.
49
LABORATORY NOTEBOOK ISSUANCE PAGE
54
.9
38
55
.8
45
58
.9
33
54
.9
38
88
.9
06
91
.2
24
92
.9
06
95
.9
6
(9
8)
10
1.
07
10
2.
91
13
8.
91
17
8.
49
XP725 Antibody Number-Lot Number 071M4826
28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80
1.3 9 10 11 12 33 34 35 36 57 58 59 60 81 82 83
Protocol: Human Pancreatic Polypeptide (PP) ELISA KIT 96-Well Plate
Expected
(pg/mL)
Observed
(pg/mL)
% Of
Expected
1 50 760 760
25 380 351 92%
10 152 148 97%
5 76 84 111%
Impurities & Related Compounds: Reference Materials
614-80-2
103-84-4
100-02-7
539-03-7
123-30-8
59-66-5
14949-00-9
55079-83-9
54350-48-0
59277-89-3
106685-40-9
33626-98-1
106685-41-0
43109-77-9
932033-57-3
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
133, 3058-3061 (1993).
9. Vita, N., et al., FEBS Lett., 335, 1-5 (1993).
10. Vale, W.W., et al., Endocrinologist, 7, 3S-9S (1997).
11. Dautzenberg, F.M., et al., Peptides, 22, 753-760 (2001).
12. Dautzenberg
Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation
(min) %A %B
Flow
µL/min
0 15 85 760
0.8 15 85 760
4 100 0 500
5 100 0 500
6 15 85 500
Time
(min) %A %B
Flow
µL/min
0 17 83 760
0.4 17 83 760
4 100
Analytix Reporter Issue 11 2022
analysis of high fat content food
samples using a matrix-compatible coating, Talanta. 167 (2017)
754–760. https://doi.org/10.1016/j.talanta.2017.01.064.
6. Souza-Silva E.A. ; Pawliszyn J., Optimization
XP725 Antibody List
http://www.sigmaaldrich.com/ProductLookup.html?ProdNo=G7670&Brand=SIGMA�
3 9
3 9
3 9
3 9
3 9
3 9
3 9
T 3
3 9
3 9
334 HDAC-7 H6663 56233, 51564 HDAC7A,Hdac7a NP_062518.2,NP_057680.3 M y y n/d
List of Antibodies
y n/d n/d
757 VGLUT 2 V2639 P n/d n/d y
758 Vimentin V6389 M y n/d y
759 Vinculin V4505 M y y n/d
760 Vitronectin V7881 M y n/d n/d
761 WAVE W0392 P y y y
762 WSTF W3516 P y y n/d
763
Halal Certificate
FCC, FG W218707 B25374 HC-22SI6K50
759. ISOBUTYL BUTYRATE, NATURAL W218715 C44261 HC-22SIT392
760. ISOBUTYL CINNAMATE 98%, FCC, FG W219304 B71323 HC-22SIDS67
This is to certify that the following
Halal Certificate
FCC, FG W218707 B25374 HC-23SIDG29
759. ISOBUTYL BUTYRATE, NATURAL W218715 C44261 HC-23SI8S71
760. ISOBUTYL CINNAMATE 98%, FCC, FG W219304 B71323 HC-23SI4846
This is to certify that the following
XP725 Antibody List 013M4793
112402.1,NP_003371.2 M y n/d y
759 Vinculin V4505 22330, 7414 VCL,Vcl NP_033528.3,NP_054706.1 M y y n/d
760 Vitronectin V7881 7448 VTN NP_000629.3 M y n/d n/d
761 WAVE W0392 294568, 8936, 83767 Wasf1,WASF1 NP
Brochure: HPLC Method Development Guide
) potentials applied to
them. The HPLC system handles dissolved analytes under
ambient pressure (760 Torr) and delivers the sample
to the MS, where the detection of the gaseous, ionized
samples is performed
XP725 Worksheet for Lot Number 071M4826
I0505
756 4 4 5 4 IkB a I0505
757 4 4 5 5 IKKa I6139
758 4 4 5 6 IKKa I6139
759 4 4 5 7 ILK I0783
760 4 4 5 8 ILK I0783
761 4 4 6 1 ILK I1907
762 4 4